SCHEMBL20577952

SCHEMBL20577952

O=C(Nc1cccc(Nc2ncccc2-c2ncnc3[nH]ccc23)c1)c1cc(C(F)(F)F)c(Cl)cc1F

nearest known ligand 0.59

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
KDR P35968 13/20 0.59
BRAF P15056 7/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20577872 0.88 KDR (0.57) KDRBRAF
SCHEMBL20577758 0.87 KDR (0.60) KDRBRAF
SCHEMBL28679600 0.85 KDR (0.62) KDRBRAF
SCHEMBL20577720 0.85 KDR (0.70) KDRBRAF
SCHEMBL20577859 0.84 KDR (0.65) KDRBRAF
SCHEMBL20577809 0.84 KDR (0.63) KDRBRAF
SCHEMBL20578165 0.84 KDR (0.63) KDRBRAF
SCHEMBL20577909 0.81 KDR (0.63) KDRBRAF
SCHEMBL19233425 0.81 KDR (0.81) KDRBRAF
SCHEMBL29448689 0.80 KDR (0.77) KDRBRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109071543-B Pyridine derivatives inhibiting RAF kinase and vascular endothelial growth factor receptor, process for their preparation, pharmaceutical compositions containing them and their use 三进制药株式会社 2021-07-16 CN disclosed
EP-3412670-A1 PYRIDINE DERIVATIVE INHIBITING RAF KINASE AND VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR, METHOD FOR PREPARING SAME, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND USE THEREOF Samjin Pharmaceutical Co., Ltd. (KR) 2018-12-12 EP disclosed